New potential strategy to combat Alzheimer’s disease
Researchers have revealed the molecular mechanism behind a rare mutation has been associated with numerous neurodegenerative diseases...
List view / Grid view
Researchers have revealed the molecular mechanism behind a rare mutation has been associated with numerous neurodegenerative diseases...
Antibody targets thought to cause the most damage in neurological disorders, creates potential for a unified treatment approach...
Scientists have used artificial intelligence techniques and big data to develop an algorithm capable of recognising the signatures of dementia two years before its onset, using a single amyloid PET scan...
A collaboration between Prof Lucía Chávez-Gutiérrez and Prof Bart De Strooper of VIB-KU Leuven has revealed the molecular basis of the hereditary form of Alzheimer’s disease that strikes early in life.
Physical biomarkers have been discovered that may help diagnose the changes to proteins found in the spinal fluid and blood of Alzheimer's patients...
Evidence that the activation of a biological pathway necroptosis is closely linked with Alzheimer's...
Researchers have identified two genes that influence a person’s risk of developing Alzheimer’s disease.
Researchers at the MRC Laboratory of Molecular Biology (LMB) have, for the first time, revealed the atomic structures of one of the two types of the abnormal filaments which lead to Alzheimer's disease.
Obese mice with a particular version of a gene strongly associated with Alzheimer's disease (AD) in humans show increased Alzheimer's pathology, according to new research published in eNeuro.
Research into innovative small molecule therapeutics with disease modifying potential in Alzheimer’s disease (AD) has been conducted at Alzheon since 2013.
A study has found that abnormal proteins found in Alzheimer's disease, Parkinson's disease, and Huntington's disease all share a ability to cause damage...
In a new study researchers measured how deposits of the pathological protein tau spread through the brain over the course of Alzheimer’s disease.
A new cell separator that began life as a tinfoil and epoxy glue prototype built with supplies from a University shop could revolutionise stem-cell and regenerative cell-based therapies.
Cells behave differently when removed from their environments, just as cells that develop in cultures do not behave like cells in living creatures.
Alzheimer’s disease is a progressive neurodegenerative disorder that leads to dementia via advanced neuronal dysfunction and death. Currently, the predominant theory behind Alzheimer’s disease is the “amyloid hypothesis,” which states that abnormally increased levels of amyloid beta (Aβ) peptides outside of brain cells produce a variety of low molecular weight…